Cognimark
Dementia Detection in Seconds
Weston, Massachusetts, US
Operating as Cognimark, a neurology AI platform for dementia detection
How We Help
Problem Statement
Cognimark aims to improve dementia assessment and clinical trial screening by instantly analyzing routine healthcare data from Electronic Health Records (EHRs) to generate attributable cognitive scores across various dementia types and stages.
Core Technology
neurology AI platform
Key Differentiators
Instantly analyzes routine healthcare data from Electronic Health Records (EHRs); Generates attributable cognitive scores across various dementia types and stages; Improves dementia assessment and clinical trial screening
Clinical Focus
Neurology; Cognitive Health
Company Info
- Business Model
- B2B
- Website
- cognimark.ai
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Nature Medicine (2024): Differential diagnosis model with 51,269 participants; Nature Communications (2025): AI-guided stratification showing 46% slowing of cognitive decline in AD trials
MedStartr Index Score
?What do you think of Cognimark?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.